Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14.
Shogo NakamotoYukiko KajiwaraKohei TaniguchiAkira I HidaYuichiro MiyoshiTakanori KinMari YamamotoDaisuke TakabatakeShinichiro KuboHajime HikinoYutaka OgasawaraMasahiko IkedaHiroyoshi DoiharaTadahiko ShienNaruto TairaTakayuki IwamotoShinichi ToyookaPublished in: Breast cancer research and treatment (2024)
Three species in the gut microbiota had potential associations with neoadjuvant chemotherapy efficacy, but the diversity of the gut microbiota was not associated with response to chemotherapy. Further research is needed to validate our findings.